The compound has never received market authorization in Canada or anywhere else, and Metabolic Pharmaceuticals terminated clinical development in 2007 after the Phase IIb obesity trial failed
Chen, L., Jia, L., Zhang, Q., Zhou, X., Liu, Z., Li, B., et al., Anaerobe , 2017, vol
(4) Heike Stier, Evert Vos, David Kenley (2013) Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans Journal of Endocrinology and Metabolism, 2013, Volume 3 (Issue 1-2), Pages 7-15
Establish a rotation schedule and stick to it
GLP-1 receptor agonists caused thyroid C-cell tumors in rodent studies, and while human cases are rare, the FDA requires a black-box warning
Chronic wounds (like diabetic ulcers or stubborn lacerations) are generally "stuck" in the M1 inflammatory phase